Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Sireis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Implementation of Bacterial Detection Methods into Blood Donor Screening - Overview of Different TechnologiesMichael Schmidt, Walid Sireis, Erhard Seifried
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 25, 2014
Emerging Pathogens - How Safe is Blood?Michael Schmidt, Wolf-Jochen Geilenkeuser, Walid Sireis, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 7, 2012
Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient?Jens Meier, Markus M Müller, Patrick Lauscher, et al.
Cell and Tissue Banking|September 11, 2014
A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testingDieter Klarmann, Walid Sireis, Michael Hogardt, et al.
Transfusion|July 29, 2010
Recipients potentially infected with parvovirus B19 by red blood cell productsMichael Kai Hourfar, Uschi Mayr-Wohlfart, Anna Themann, et al.
Transfusion|October 12, 2002
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central EuropeW Kurt Roth, Marijke Weber, Sylvia Buhr, et al.
Transfusion|October 12, 2002
NAT for HBV and anti-HBc testing increase blood safetyW Kurt Roth, Marijke Weber, Detlev Petersen, et al.
Transfusion|May 28, 2015
Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strainsMichael Schmidt, Michael K Hourfar, Walid Sireis, et al.
Vox Sanguinis|September 9, 2005
Optimized Scansystem platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spikingMichael Schmidt, Christina Weis, Julia Heck, et al.
Annals of Hematology|June 2, 2009
Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-upGabriele Walther-Wenke, Hubert Schrezenmeier, Robert Deitenbeck, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Implementation of Bacterial Detection Methods into Blood Donor Screening - Overview of Different TechnologiesMichael Schmidt, Walid Sireis, Erhard Seifried
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 25, 2014
Emerging Pathogens - How Safe is Blood?Michael Schmidt, Wolf-Jochen Geilenkeuser, Walid Sireis, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 7, 2012
Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient?Jens Meier, Markus M Müller, Patrick Lauscher, et al.
Cell and Tissue Banking|September 11, 2014
A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testingDieter Klarmann, Walid Sireis, Michael Hogardt, et al.
Transfusion|July 29, 2010
Recipients potentially infected with parvovirus B19 by red blood cell productsMichael Kai Hourfar, Uschi Mayr-Wohlfart, Anna Themann, et al.
Transfusion|October 12, 2002
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central EuropeW Kurt Roth, Marijke Weber, Sylvia Buhr, et al.
Transfusion|October 12, 2002
NAT for HBV and anti-HBc testing increase blood safetyW Kurt Roth, Marijke Weber, Detlev Petersen, et al.
Transfusion|May 28, 2015
Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strainsMichael Schmidt, Michael K Hourfar, Walid Sireis, et al.
Vox Sanguinis|September 9, 2005
Optimized Scansystem platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spikingMichael Schmidt, Christina Weis, Julia Heck, et al.
Annals of Hematology|June 2, 2009
Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-upGabriele Walther-Wenke, Hubert Schrezenmeier, Robert Deitenbeck, et al.
Pageof 2